Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02930200 · ClinicalTrials.gov registry record · NA

Clinical Trial of an Automated Smartphone Based Smoking Cessation Treatment

A NA study, sponsored by University of Oklahoma.

Completed
Registry status
NA
Development phase
98
Enrollment target

NCT02930200 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 98 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02930200, a NA study, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
NA
Development phase
98 participants
Enrollment target

Study Summary

The primary long-term objective of this research is to reduce smoking relapse through the use of automated mobile smoking cessation interventions that tailor content (e.g., treatment messages/materials) in real-time based upon currently present symptoms. The primary short-term objective of this pilot study is to determine the initial utility of a novel smartphone based smoking cessation intervention compared with standard in-person smoking cessation clinic care and the free National Cancer Institute (NCI) QuitGuide smoking cessation application. The current pilot study is a 3 armed randomized clinical trial that aims to determine the initial utility of a novel smartphone based smoking cessation intervention compared with standard in-person smoking cessation clinic care and the free NCI QuitGuide smoking cessation application.

Interventions

  • BEHAVIORAL Treatment as Usual
  • BEHAVIORAL QuitGuide
  • BEHAVIORAL Smart-T

Trial Details

FieldValue
Enrollment Target 98 participants
Start Date 2017-05-30
Est. Completion 2018-11-01
Phase NA

Sponsor

University of Oklahoma

358 total trials

What the Registry Record Tells You About NCT02930200

The ClinicalTrials.gov registry entry for NCT02930200 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Treatment as Usual is the first listed.

NCT02930200 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02930200 about?

NCT02930200 is a clinical study titled "Clinical Trial of an Automated Smartphone Based Smoking Cessation Treatment". The primary long-term objective of this research is to reduce smoking relapse through the use of automated mobile smoking cessation interventions that tailor content (e.g., treatment messages/materials) in real-time based upon currently present symptoms. The primary short-term objective of this pilo...

What is the current status of trial NCT02930200?

This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2017-05-30. Estimated completion is 2018-11-01.

What interventions are being tested in trial NCT02930200?

The interventions under investigation include: Treatment as Usual (BEHAVIORAL), QuitGuide (BEHAVIORAL), Smart-T (BEHAVIORAL).

Who is sponsoring clinical trial NCT02930200?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.